Cylene Pharmaceuticals
closedA clinical stage private company designing and developing small molecule drugs against newly validated cancer targets.
Launch date
Employees
Market cap
-
Enterprise valuation
$48—72m (Dealroom.co estimates Sep 2010.)
San Diego California (HQ)
Authorizing premium user...